Patients who progressed to having longer episodes of subclinical atrial fibrillation (SCAF) were more than four times as likely to be hospitalized for heart failure in a one-year span, according to a study published June 4 in the Journal of the American College of Cardiology.
People who reported having stressful jobs were 48 percent more likely to develop atrial fibrillation (AFib), according to a Swedish study published in the European Journal of Preventive Cardiology.
With shorter half-lives and more predictable effects, direct oral anticoagulants (DOACs) could help simplify perioperative treatment decisions for patients with non-valvular atrial fibrillation (NVAF), suggests a meta-analysis published May 24 in Circulation.
Patients who required permanent pacemakers (PPMs) after transcatheter aortic valve replacement (TAVR) demonstrated lower survival rates and higher comorbidity burdens over a multiyear follow-up. However, they didn’t accumulate significantly greater healthcare costs, according to a study published online May 25 in JAMA Network Open.
Pfizer gave more than $10 million to a charity for heart patients while dramatically increasing the price of one of its antiarrhythmic drugs, deflecting costs from patients and leaving Medicare with a bigger bill, the U.S. Justice Department said in a May 24 settlement statement.
A smartwatch algorithm reliably differentiated atrial fibrillation (AF) from sinus rhythm among patients scheduled for elective cardioversion, showing the technology’s potential to prevent unnecessary procedures.
May 23, 2018 | Practice Management
Pregnancy increases the risk of morbidity in women who exhibit cardiovascular disease (CVD). Complications in expecting mothers may be predicted by a risk index that integrates lesion-specific, delivery-of-care and generic variables.
Haider Warraich, MD, used the recently presented CABANA trial to launch into an opinion piece about the medical community’s eagerness to embrace new technologies and invasive procedures.
One-fourth of transvenous implantable cardioverter defibrillator (ICD) leads has a mechanical complication within 10 years, according to an insurance database analysis published May 10 in the Journal of the American Heart Association.
Wearable sensors and artificial intelligence (AI) could help predict the onset of cardiovascular disease by assessing an individual's changes in aerobic responses, according to new research published on Feb. 23 in the Journal of Applied Physiology.
Even for patients with intermittent atrial fibrillation (AFib), the amount of time spent in an arrhythmic state is strongly associated with an increased risk of stroke, researchers reported in JAMA Cardiology.
A His bundle pacing (HBP) strategy was associated with a significant reduction in hospitalizations for heart failure when compared to pacemaker implantation via the right ventricle, according to a study published online May 14 in the Journal of the American College of Cardiology.
Women who received catheter ablation in the FIRE AND ICE trial were 37 percent more likely than men to have a recurrence of atrial arrhythmia and 36 percent more likely to be rehospitalized for cardiovascular causes, according to an analysis published April 26 in Circulation: Arrhythmia and Electrophysiology.
Watchman-related thrombi developed in 3.7 percent of patients who were implanted with the device, resulting in a threefold risk of stroke or systemic embolism, according to a meta-analysis of clinical trials and registries published online May 11 in Circulation.
A novel device placed under the sternum outside of the heart and veins has the potential to deliver pacing and defibrillation therapy, according to a feasibility study presented at the Heart Rhythm Society’s annual scientific sessions.
A sensing filter added to Boston Scientific’s Emblem subcutaneous implantable cardioverter defibrillators (S-ICDs) more than halved the number of inappropriate shocks given to patients over a one-year period, according to a real-world European study presented May 11 at the Heart Rhythm Society’s annual scientific sessions in Boston.
Physicians and patients have long awaited the next step beyond catheter ablation for ventricular tachycardia (VT). Could noninvasive stereotactic body radiation be that
Atrial fibrillation (AFib) should never be considered fully cured, according to a recent study in The BMJ, because patients with this designation carry higher risks of stroke and death compared to people who have never had the arrhythmia.
Catheter ablation was found to be superior to optimal drug therapy for the primary treatment of atrial fibrillation (AFib) in the randomized CABANA trial presented May 10 at the Heart Rhythm Society’s annual scientific sessions in Boston. However, there was a caveat.
Administering antibiotics incrementally in the perioperative stage has the potential to modestly reduce infections related to cardiac implantable electronic devices (CIEDs), according to a study presented May 10 at the Heart Rhythm Society’s annual scientific sessions in Boston.
An analysis of more than one million post-9/11 veterans suggests a new diagnosis of post-traumatic stress disorder (PTSD) is associated with a greater likelihood of developing atrial fibrillation (AF). The study is scheduled to be presented May 11 at the Heart Rhythm Society’s annual scientific sessions in Boston.